ID   STK33_HUMAN             Reviewed;         514 AA.
AC   Q9BYT3; Q658S6; Q8NEF5;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   12-OCT-2022, entry version 160.
DE   RecName: Full=Serine/threonine-protein kinase 33;
DE            EC=2.7.11.1;
GN   Name=STK33;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Uterus;
RX   PubMed=11738831; DOI=10.1016/s0378-1119(01)00780-6;
RA   Mujica A.O., Hankeln T., Schmidt E.R.;
RT   "A novel serine/threonine kinase gene, STK33, on human chromosome
RT   11p15.3.";
RL   Gene 280:175-181(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 246-514 (ISOFORM 2).
RC   TISSUE=Stomach;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   TISSUE SPECIFICITY.
RX   PubMed=16176263; DOI=10.1111/j.1742-4658.2005.04900.x;
RA   Mujica A.O., Brauksiepe B., Saaler-Reinhardt S., Reuss S., Schmidt E.R.;
RT   "Differential expression pattern of the novel serine/threonine kinase,
RT   STK33, in mice and men.";
RL   FEBS J. 272:4884-4898(2005).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   FUNCTION.
RX   PubMed=21742770; DOI=10.1158/0008-5472.can-11-0778;
RA   Babij C., Zhang Y., Kurzeja R.J., Munzli A., Shehabeldin A., Fernando M.,
RA   Quon K., Kassner P.D., Ruefli-Brasse A.A., Watson V.J., Fajardo F.,
RA   Jackson A., Zondlo J., Sun Y., Ellison A.R., Plewa C.A., San Miguel T.,
RA   Robinson J., McCarter J., Schwandner R., Judd T., Carnahan J., Dussault I.;
RT   "STk33 kinase activity is non-essential in KRAS-dependent cancer cells.";
RL   Cancer Res. 71:5818-5826(2011).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] ASP-98; VAL-160; GLU-436; THR-437 AND
RP   GLU-458.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase which phosphorylates VIME.
CC       May play a specific role in the dynamic behavior of the intermediate
CC       filament cytoskeleton by phosphorylation of VIME (By similarity). Not
CC       essential for the survival of KRAS-dependent AML cell lines.
CC       {ECO:0000250, ECO:0000269|PubMed:21742770}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts with VIME. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BYT3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BYT3-2; Sequence=VSP_017939;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, fetal lung and heart,
CC       followed by pituitary gland, kidney, interventricular septum, pancreas,
CC       heart, trachea, thyroid gland and uterus. Weak hybridization signals
CC       were observed in the following tissues: amygdala, aorta, esophagus,
CC       colon ascending, colon transverse, skeletal muscle, spleen, peripheral
CC       blood leukocyte, lymph node, bone marrow, placenta, prostate, liver,
CC       salivary gland, mammary gland, some tumor cell lines, fetal brain,
CC       fetal liver, fetal spleen and fetal thymus. No signal at all was
CC       detectable in RNA from tissues of the nervous system.
CC       {ECO:0000269|PubMed:11738831, ECO:0000269|PubMed:16176263}.
CC   -!- PTM: Autophosphorylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. CaMK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ303380; CAC29064.1; -; mRNA.
DR   EMBL; AK093251; BAC04109.1; -; mRNA.
DR   EMBL; BC031231; AAH31231.1; -; mRNA.
DR   EMBL; AL833011; CAH56302.1; -; mRNA.
DR   CCDS; CCDS7789.1; -. [Q9BYT3-1]
DR   RefSeq; NP_001275987.1; NM_001289058.1.
DR   RefSeq; NP_001275988.1; NM_001289059.1.
DR   RefSeq; NP_001275990.1; NM_001289061.1. [Q9BYT3-1]
DR   RefSeq; NP_112168.1; NM_030906.3. [Q9BYT3-1]
DR   RefSeq; XP_011518590.1; XM_011520288.2.
DR   RefSeq; XP_011518592.1; XM_011520290.2. [Q9BYT3-1]
DR   RefSeq; XP_011518594.1; XM_011520292.2.
DR   RefSeq; XP_011518595.1; XM_011520293.2.
DR   RefSeq; XP_011518596.1; XM_011520294.1.
DR   RefSeq; XP_011518597.1; XM_011520295.2. [Q9BYT3-1]
DR   RefSeq; XP_016873632.1; XM_017018143.1.
DR   RefSeq; XP_016873633.1; XM_017018144.1. [Q9BYT3-1]
DR   RefSeq; XP_016873634.1; XM_017018145.1. [Q9BYT3-1]
DR   RefSeq; XP_016873635.1; XM_017018146.1. [Q9BYT3-1]
DR   RefSeq; XP_016873636.1; XM_017018147.1. [Q9BYT3-1]
DR   RefSeq; XP_016873637.1; XM_017018148.1. [Q9BYT3-1]
DR   RefSeq; XP_016873638.1; XM_017018149.1.
DR   RefSeq; XP_016873639.1; XM_017018150.1.
DR   RefSeq; XP_016873640.1; XM_017018151.1.
DR   RefSeq; XP_016873641.1; XM_017018152.1. [Q9BYT3-1]
DR   RefSeq; XP_016873642.1; XM_017018153.1. [Q9BYT3-1]
DR   RefSeq; XP_016873643.1; XM_017018154.1. [Q9BYT3-1]
DR   RefSeq; XP_016873644.1; XM_017018155.1. [Q9BYT3-1]
DR   RefSeq; XP_016873645.1; XM_017018156.1. [Q9BYT3-1]
DR   RefSeq; XP_016873648.1; XM_017018159.1. [Q9BYT3-2]
DR   RefSeq; XP_016873649.1; XM_017018160.1.
DR   AlphaFoldDB; Q9BYT3; -.
DR   SMR; Q9BYT3; -.
DR   BioGRID; 122426; 15.
DR   IntAct; Q9BYT3; 20.
DR   STRING; 9606.ENSP00000416750; -.
DR   BindingDB; Q9BYT3; -.
DR   ChEMBL; CHEMBL6005; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9BYT3; -.
DR   GuidetoPHARMACOLOGY; 2221; -.
DR   GlyGen; Q9BYT3; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9BYT3; -.
DR   PhosphoSitePlus; Q9BYT3; -.
DR   BioMuta; STK33; -.
DR   DMDM; 74761329; -.
DR   EPD; Q9BYT3; -.
DR   jPOST; Q9BYT3; -.
DR   MassIVE; Q9BYT3; -.
DR   MaxQB; Q9BYT3; -.
DR   PaxDb; Q9BYT3; -.
DR   PeptideAtlas; Q9BYT3; -.
DR   PRIDE; Q9BYT3; -.
DR   ProteomicsDB; 79704; -. [Q9BYT3-1]
DR   ProteomicsDB; 79705; -. [Q9BYT3-2]
DR   Antibodypedia; 11459; 448 antibodies from 34 providers.
DR   DNASU; 65975; -.
DR   Ensembl; ENST00000315204.5; ENSP00000320754.1; ENSG00000130413.16. [Q9BYT3-1]
DR   Ensembl; ENST00000396672.5; ENSP00000379905.1; ENSG00000130413.16. [Q9BYT3-1]
DR   Ensembl; ENST00000447869.5; ENSP00000416750.1; ENSG00000130413.16. [Q9BYT3-1]
DR   Ensembl; ENST00000687296.1; ENSP00000509322.1; ENSG00000130413.16. [Q9BYT3-1]
DR   GeneID; 65975; -.
DR   KEGG; hsa:65975; -.
DR   MANE-Select; ENST00000687296.1; ENSP00000509322.1; NM_001352389.2; NP_001339318.1.
DR   UCSC; uc001mgi.3; human. [Q9BYT3-1]
DR   CTD; 65975; -.
DR   DisGeNET; 65975; -.
DR   GeneCards; STK33; -.
DR   HGNC; HGNC:14568; STK33.
DR   HPA; ENSG00000130413; Tissue enhanced (choroid plexus, testis).
DR   MIM; 607670; gene.
DR   neXtProt; NX_Q9BYT3; -.
DR   OpenTargets; ENSG00000130413; -.
DR   PharmGKB; PA37900; -.
DR   VEuPathDB; HostDB:ENSG00000130413; -.
DR   eggNOG; KOG0032; Eukaryota.
DR   GeneTree; ENSGT00940000159050; -.
DR   InParanoid; Q9BYT3; -.
DR   OMA; CGEPPFM; -.
DR   OrthoDB; 330091at2759; -.
DR   PhylomeDB; Q9BYT3; -.
DR   TreeFam; TF314166; -.
DR   PathwayCommons; Q9BYT3; -.
DR   SignaLink; Q9BYT3; -.
DR   BioGRID-ORCS; 65975; 10 hits in 1102 CRISPR screens.
DR   ChiTaRS; STK33; human.
DR   GenomeRNAi; 65975; -.
DR   Pharos; Q9BYT3; Tchem.
DR   PRO; PR:Q9BYT3; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9BYT3; protein.
DR   Bgee; ENSG00000130413; Expressed in right uterine tube and 112 other tissues.
DR   ExpressionAtlas; Q9BYT3; baseline and differential.
DR   Genevisible; Q9BYT3; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISS:UniProtKB.
DR   GO; GO:0044773; P:mitotic DNA damage checkpoint signaling; IBA:GO_Central.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..514
FT                   /note="Serine/threonine-protein kinase 33"
FT                   /id="PRO_0000232644"
FT   DOMAIN          116..381
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          65..91
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          402..468
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          485..514
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        65..80
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        402..423
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        452..468
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        489..503
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        238
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         122..130
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         145
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         407
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q924X7"
FT   VAR_SEQ         383..448
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_017939"
FT   VARIANT         60
FT                   /note="K -> E (in dbSNP:rs60786172)"
FT                   /id="VAR_061746"
FT   VARIANT         98
FT                   /note="E -> D (in dbSNP:rs34525052)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041172"
FT   VARIANT         160
FT                   /note="L -> V (in a lung large cell carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041173"
FT   VARIANT         436
FT                   /note="D -> E (in dbSNP:rs3751096)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041174"
FT   VARIANT         437
FT                   /note="A -> T (in dbSNP:rs3751095)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041175"
FT   VARIANT         458
FT                   /note="A -> E (in dbSNP:rs35296353)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041176"
FT   CONFLICT        436..437
FT                   /note="DA -> ET (in Ref. 3; AAH31231)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        451
FT                   /note="A -> T (in Ref. 3; AAH31231)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   514 AA;  57831 MW;  C251691ECB2DAC1A CRC64;
     MADSGLDKKS TKCPDCSSAS QKDVLCVCSS KTRVPPVLVV EMSQTSSIGS AESLISLERK
     KEKNINRDIT SRKDLPSRTS NVERKASQQQ WGRGNFTEGK VPHIRIENGA AIEEIYTFGR
     ILGKGSFGIV IEATDKETET KWAIKKVNKE KAGSSAVKLL EREVNILKSV KHEHIIHLEQ
     VFETPKKMYL VMELCEDGEL KEILDRKGHF SENETRWIIQ SLASAIAYLH NNDIVHRDLK
     LENIMVKSSL IDDNNEINLN IKVTDFGLAV KKQSRSEAML QATCGTPIYM APEVISAHDY
     SQQCDIWSIG VVMYMLLRGE PPFLASSEEK LFELIRKGEL HFENAVWNSI SDCAKSVLKQ
     LMKVDPAHRI TAKELLDNQW LTGNKLSSVR PTNVLEMMKE WKNNPESVEE NTTEEKNKPS
     TEEKLKSYQP WGNVPDANYT SDEEEEKQST AYEKQFPATS KDNFDMCSSS FTSSKLLPAE
     IKGEMEKTPV TPSQGTATKY PAKSGALSRT KKKL
//
